|
Game Changers
Volume V, Issue 44 | Nov. 4, 2016
South Florida Healthcare Professionals on the Move:
Promotions, Achievements, Engagements & Accolades
|
From the publisher of FHIweekly, Specialty Focus & FloridaHealthIndustry.com
|
|
|
|
Current Events
|
SFHNG presents
Healthcare Breakfast Networker
Wed., 11/16/16 | 7:45-10 am
Broward Health Imperial Point
~~~~~~~~
PBCMS presents
2016 Starfish & Snowflake Gala
Sat., 12/3/16 | 6:30-10:30 pm
~~~~~~~~
The Healthcare Roundtable presents
Bundled Payments
Tues., 12/6/16 | 7:30-9:30 am
First Citizens Bank | Ft. Lauderdale
Register/Learn More>>
____________
|
Have You Completed Your Required CME Hours?
|
Sat., 12/10/16 | 9 am - 1:15 pm
Pullman Miami Hotel
5800 Blue Lagoon Drive Miami, FL 33126
Learn More>>
|
|
Publisher of
:
Week in Review, Specialty Focus, Updates in Pediatrics, FHIweekly & Game Changers
INFORM | CONNECT | ENGAGE
|
Do You Know a Healthcare Game Changer?
|
|
|
Brain Tunnelgenix Technologies Opens R&D Office in Florida for Brain Temperature-Monitoring Solutions -- Company Develops, Markets And Sells Systems For Personal, Professional, Athletic, Military and Medical Use
|
Brain Tunnelgenix Technologies (BTT Corp.) has opened a Research and Development office in Aventura for its proprietary brain temperature monitoring solutions. Company founder and president
Dr. M. Marc Abreu leads a management team that markets, distributes and develops proprietary and worldwide, patented products.
"Aventura is an ideal location to build a customer base and create national and international collaborations," Dr. Abreu said. "We can draw from a wealth of business and technology talent and make global connections."
Dr. Abreu is a pioneer in research on body thermal energy and brain thermodynamics, having studied the subject as part of the clinical faculty at the
Yale School of Medicine for more than a decade. He discovered the brain thermal tunnel, which for the first time in history enabled noninvasive, continuous measurement of human brain temperature.
BTT Corp. offers a broad range of solutions for improving health by making use of the thermophysical and bi-directional tunnel that starts at the intersection of the nose and eyebrow where thermal signature patterns are captured from the brain. With that information, their scientists and researchers are developing diagnostics and specific therapies using brain thermal modulation to help manage and treat various conditions and diseases.
Read More>>
|
The Campbell Foundation Awards Grant to Explore Brain Inflammation and Mental Decline in HIV Patients
|
The Fort Lauderdale based
Campbell Foundation, a nonprofit organization dedicated to funding HIV/AIDS research, has awarded a $77,495 grant to
Cristina Granziera, MD, PhD. of
Massachusetts General Hospital. The money will be used to study the gut-brain relationship in HIV-positive patients.
Dr. Granziera and her team will use non-invasive imaging (magnetic resonance imaging and positron emission tomography) to determine whether HIV-positive patients with dysbiotic, or imbalanced, gut microbiomes have higher brain inflammation than HIV-positive patients with normal gut microbiomes.
Research has revealed that the gut holds the key to much of our overall health and well-being. An imbalance of bacteria in the gut can result in myriad problems including inflammation of the brain. This, in turn, can result in HIV-associated neurocognitive disorders.
|
West Boca Medical Center Only Hospital in Palm Beach County to Earn 10th Consecutive Top Score in Patient Safety
|
Boca Raton based
West Boca Medical Center recently received an "A" Hospital Safety Score from
The Leapfrog Group, a non-profit organization that provides patient safety information to consumers and consultation services for network inclusion to insurers and self-insured employers.
"This is a significant milestone for West Boca Medical Center," said
Mitch Feldman, hospital CEO. "We are the only hospital in Palm Beach County to maintain a superior score 10 times in a row, since the inception of the award in 2012. We remain dedicated to patient safety, and the continued acknowledgement from The Leapfrog Group speaks to our commitment to this goal."
|
|
|
|
|
|
|
|